Search:
   

Tuesday, April 2, 2019

Equity Corporate Actions Alert #2019 - 65
(UPDATED - Merger Effective) Information Regarding the Merger of Celgene Corporation (CELG) and Bristol-Myers Squibb Company (NYSE: BMY)

Category:

  • Industry Announcement

Markets Impacted:

Contact Information:

Resources:

Shareholders of Celgene Corporation (CELG) met on Friday, April 12, 2019 and voted to approve the proposed merger of the company with and into Bristol-Myers Squibb Company (NYSE: BMY). The merger became effective today, Wednesday, November 20, 2019. The details are as follows:

Company: Celgene Corporation
Issue: Common Stock
CUSIP#: 151020104
Symbol: CELG
Last Trading Date: Wednesday, November 20, 2019
Marketplace Effective Date for Suspension: Thursday, November 21, 2019
Merger Consideration: $50.00 in cash, One (1) share of Bristol-Myers Squibb Company common stock, and One (1) Contingent Value Right (CVR) for each share of CELG held.

Please follow Nasdaq on Facebook RSS and Twitter.

Nasdaq (Nasdaq: NDAQ) is a leading global provider of trading, clearing, exchange technology, listing, information and public company services. Through its diverse portfolio of solutions, Nasdaq enables customers to plan, optimize and execute their business vision with confidence, using proven technologies that provide transparency and insight for navigating today's global capital markets. As the creator of the world's first electronic stock market, its technology powers more than 90 marketplaces in 50 countries, and 1 in 10 of the world's securities transactions. Nasdaq is home to approximately 3,900 total listings with a market value of approximately $13 trillion. To learn more, visit: business.nasdaq.com.

View NASDAQTrader.com Mobile